nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ALB—primary biliary cirrhosis	0.56	1	CbGaD
Alfentanil—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.108	0.426	CbGbCtD
Alfentanil—ABCB1—Colchicine—primary biliary cirrhosis	0.0914	0.359	CbGbCtD
Alfentanil—CYP3A4—Colchicine—primary biliary cirrhosis	0.0547	0.215	CbGbCtD
Alfentanil—ORM1—bile—primary biliary cirrhosis	0.0144	0.486	CbGeAlD
Alfentanil—ORM1—gall bladder—primary biliary cirrhosis	0.004	0.135	CbGeAlD
Alfentanil—ABCB1—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00394	0.0826	CbGpPWpGaD
Alfentanil—ALB—gall bladder—primary biliary cirrhosis	0.00351	0.118	CbGeAlD
Alfentanil—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00299	0.0626	CbGpPWpGaD
Alfentanil—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00243	0.0509	CbGpPWpGaD
Alfentanil—ABCB1—Abacavir transmembrane transport—ABCG2—primary biliary cirrhosis	0.00204	0.0427	CbGpPWpGaD
Alfentanil—CYP3A7—liver—primary biliary cirrhosis	0.00185	0.0625	CbGeAlD
Alfentanil—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00185	0.0171	CcSEcCtD
Alfentanil—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00185	0.0171	CcSEcCtD
Alfentanil—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00184	0.0386	CbGpPWpGaD
Alfentanil—Eye disorder—Colchicine—primary biliary cirrhosis	0.00183	0.017	CcSEcCtD
Alfentanil—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00177	0.0164	CcSEcCtD
Alfentanil—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00173	0.016	CcSEcCtD
Alfentanil—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00173	0.016	CcSEcCtD
Alfentanil—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.0017	0.0157	CcSEcCtD
Alfentanil—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.0017	0.0157	CcSEcCtD
Alfentanil—ABCB1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00165	0.0345	CbGpPWpGaD
Alfentanil—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00165	0.0153	CcSEcCtD
Alfentanil—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00165	0.0153	CcSEcCtD
Alfentanil—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00164	0.0151	CcSEcCtD
Alfentanil—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00164	0.0151	CcSEcCtD
Alfentanil—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.0016	0.0148	CcSEcCtD
Alfentanil—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.0016	0.0148	CcSEcCtD
Alfentanil—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00159	0.0147	CcSEcCtD
Alfentanil—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00159	0.0147	CcSEcCtD
Alfentanil—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00159	0.0147	CcSEcCtD
Alfentanil—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00159	0.0147	CcSEcCtD
Alfentanil—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.00158	0.0146	CcSEcCtD
Alfentanil—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.00158	0.0146	CcSEcCtD
Alfentanil—CYP3A7-CYP3A51P—liver—primary biliary cirrhosis	0.00158	0.0531	CbGeAlD
Alfentanil—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00157	0.0146	CcSEcCtD
Alfentanil—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00157	0.0146	CcSEcCtD
Alfentanil—CYP3A5—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.00139	0.0292	CbGpPWpGaD
Alfentanil—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00137	0.0127	CcSEcCtD
Alfentanil—Skin disorder—Colchicine—primary biliary cirrhosis	0.00135	0.0125	CcSEcCtD
Alfentanil—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00135	0.0125	CcSEcCtD
Alfentanil—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00135	0.0125	CcSEcCtD
Alfentanil—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00134	0.0124	CcSEcCtD
Alfentanil—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00134	0.0124	CcSEcCtD
Alfentanil—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00133	0.0123	CcSEcCtD
Alfentanil—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00133	0.0123	CcSEcCtD
Alfentanil—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00132	0.0123	CcSEcCtD
Alfentanil—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00132	0.0123	CcSEcCtD
Alfentanil—Hypotension—Colchicine—primary biliary cirrhosis	0.0013	0.0121	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.0013	0.012	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.0013	0.012	CcSEcCtD
Alfentanil—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.00126	0.0117	CcSEcCtD
Alfentanil—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.00126	0.0117	CcSEcCtD
Alfentanil—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.0114	CcSEcCtD
Alfentanil—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.0114	CcSEcCtD
Alfentanil—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00122	0.0113	CcSEcCtD
Alfentanil—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00122	0.0113	CcSEcCtD
Alfentanil—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00122	0.0113	CcSEcCtD
Alfentanil—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00122	0.0113	CcSEcCtD
Alfentanil—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00121	0.0112	CcSEcCtD
Alfentanil—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00121	0.0112	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.0012	0.0111	CcSEcCtD
Alfentanil—Fatigue—Colchicine—primary biliary cirrhosis	0.0012	0.0111	CcSEcCtD
Alfentanil—CYP3A5—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00119	0.0248	CbGpPWpGaD
Alfentanil—ORM1—liver—primary biliary cirrhosis	0.00117	0.0396	CbGeAlD
Alfentanil—ABCB1—Abacavir transport and metabolism—ABCG2—primary biliary cirrhosis	0.00117	0.0245	CbGpPWpGaD
Alfentanil—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.0108	CcSEcCtD
Alfentanil—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.0108	CcSEcCtD
Alfentanil—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00111	0.0103	CcSEcCtD
Alfentanil—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00111	0.0103	CcSEcCtD
Alfentanil—Urticaria—Colchicine—primary biliary cirrhosis	0.00111	0.0103	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00108	0.01	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00108	0.01	CcSEcCtD
Alfentanil—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00108	0.01	CcSEcCtD
Alfentanil—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00108	0.01	CcSEcCtD
Alfentanil—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00991	CcSEcCtD
Alfentanil—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00991	CcSEcCtD
Alfentanil—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00955	CcSEcCtD
Alfentanil—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00955	CcSEcCtD
Alfentanil—ALB—liver—primary biliary cirrhosis	0.00103	0.0347	CbGeAlD
Alfentanil—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00103	0.00951	CcSEcCtD
Alfentanil—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00101	0.0213	CbGpPWpGaD
Alfentanil—Asthenia—Colchicine—primary biliary cirrhosis	0.001	0.00926	CcSEcCtD
Alfentanil—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000994	0.00921	CcSEcCtD
Alfentanil—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000994	0.00921	CcSEcCtD
Alfentanil—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000989	0.00917	CcSEcCtD
Alfentanil—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000989	0.00917	CcSEcCtD
Alfentanil—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000922	0.00854	CcSEcCtD
Alfentanil—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000922	0.00854	CcSEcCtD
Alfentanil—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000901	0.0189	CbGpPWpGaD
Alfentanil—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000898	0.00832	CcSEcCtD
Alfentanil—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000898	0.00832	CcSEcCtD
Alfentanil—Vomiting—Colchicine—primary biliary cirrhosis	0.000886	0.0082	CcSEcCtD
Alfentanil—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000886	0.0082	CcSEcCtD
Alfentanil—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000886	0.0082	CcSEcCtD
Alfentanil—Rash—Colchicine—primary biliary cirrhosis	0.000878	0.00814	CcSEcCtD
Alfentanil—Dermatitis—Colchicine—primary biliary cirrhosis	0.000878	0.00813	CcSEcCtD
Alfentanil—Headache—Colchicine—primary biliary cirrhosis	0.000873	0.00808	CcSEcCtD
Alfentanil—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000828	0.00767	CcSEcCtD
Alfentanil—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000828	0.00767	CcSEcCtD
Alfentanil—Nausea—Colchicine—primary biliary cirrhosis	0.000827	0.00766	CcSEcCtD
Alfentanil—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000796	0.00737	CcSEcCtD
Alfentanil—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000796	0.00737	CcSEcCtD
Alfentanil—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000789	0.00731	CcSEcCtD
Alfentanil—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000789	0.00731	CcSEcCtD
Alfentanil—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000788	0.0073	CcSEcCtD
Alfentanil—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000788	0.0073	CcSEcCtD
Alfentanil—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000788	0.0165	CbGpPWpGaD
Alfentanil—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000784	0.00726	CcSEcCtD
Alfentanil—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000784	0.00726	CcSEcCtD
Alfentanil—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.000773	0.0162	CbGpPWpGaD
Alfentanil—OPRM1—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.000752	0.0158	CbGpPWpGaD
Alfentanil—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000743	0.00689	CcSEcCtD
Alfentanil—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000743	0.00689	CcSEcCtD
Alfentanil—CYP3A5—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.00072	0.0151	CbGpPWpGaD
Alfentanil—OPRM1—TCR Signaling Pathway—CD3D—primary biliary cirrhosis	0.000713	0.0149	CbGpPWpGaD
Alfentanil—CYP3A5—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000682	0.0143	CbGpPWpGaD
Alfentanil—CYP3A5—liver—primary biliary cirrhosis	0.000653	0.022	CbGeAlD
Alfentanil—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.000648	0.0136	CbGpPWpGaD
Alfentanil—OPRM1—TCR Signaling Pathway—MAP3K14—primary biliary cirrhosis	0.000621	0.013	CbGpPWpGaD
Alfentanil—ABCB1—epithelium—primary biliary cirrhosis	0.000612	0.0206	CbGeAlD
Alfentanil—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000555	0.0116	CbGpPWpGaD
Alfentanil—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.000551	0.0116	CbGpPWpGaD
Alfentanil—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000543	0.0114	CbGpPWpGaD
Alfentanil—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000517	0.0108	CbGpPWpGaD
Alfentanil—OPRM1—IL4-mediated signaling events—COL1A1—primary biliary cirrhosis	0.000505	0.0106	CbGpPWpGaD
Alfentanil—ABCB1—ABC-family proteins mediated transport—ABCC2—primary biliary cirrhosis	0.000494	0.0104	CbGpPWpGaD
Alfentanil—CYP3A4—liver—primary biliary cirrhosis	0.00049	0.0165	CbGeAlD
Alfentanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000485	0.0102	CbGpPWpGaD
Alfentanil—ALB—FOXA2 and FOXA3 transcription factor networks—IGFBP1—primary biliary cirrhosis	0.000458	0.00961	CbGpPWpGaD
Alfentanil—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.000455	0.00953	CbGpPWpGaD
Alfentanil—OPRM1—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.000415	0.0087	CbGpPWpGaD
Alfentanil—CYP3A5—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.0004	0.00838	CbGpPWpGaD
Alfentanil—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—primary biliary cirrhosis	0.000376	0.00788	CbGpPWpGaD
Alfentanil—OPRM1—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.000354	0.00741	CbGpPWpGaD
Alfentanil—OPRM1—IL4-mediated signaling events—CD40LG—primary biliary cirrhosis	0.000351	0.00736	CbGpPWpGaD
Alfentanil—ABCB1—liver—primary biliary cirrhosis	0.000347	0.0117	CbGeAlD
Alfentanil—OPRM1—IL4-mediated signaling events—IL4—primary biliary cirrhosis	0.000342	0.00716	CbGpPWpGaD
Alfentanil—OPRM1—IL4-mediated signaling events—RPS6KB1—primary biliary cirrhosis	0.000342	0.00716	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.000335	0.00702	CbGpPWpGaD
Alfentanil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000335	0.00701	CbGpPWpGaD
Alfentanil—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—primary biliary cirrhosis	0.000328	0.00688	CbGpPWpGaD
Alfentanil—OPRM1—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.000321	0.00673	CbGpPWpGaD
Alfentanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000319	0.00668	CbGpPWpGaD
Alfentanil—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000317	0.00664	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.000304	0.00637	CbGpPWpGaD
Alfentanil—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000302	0.00632	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—CXCR5—primary biliary cirrhosis	0.000298	0.00625	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.000296	0.0062	CbGpPWpGaD
Alfentanil—ALB—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.000291	0.00611	CbGpPWpGaD
Alfentanil—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—primary biliary cirrhosis	0.00029	0.00609	CbGpPWpGaD
Alfentanil—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000282	0.00591	CbGpPWpGaD
Alfentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000277	0.0058	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—CXCL9—primary biliary cirrhosis	0.000271	0.00568	CbGpPWpGaD
Alfentanil—ABCB1—HIF-1-alpha transcription factor network—ABCG2—primary biliary cirrhosis	0.000259	0.00542	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000237	0.00497	CbGpPWpGaD
Alfentanil—ALB—Vitamin B12 Metabolism—CCL5—primary biliary cirrhosis	0.000221	0.00463	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000215	0.00451	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000188	0.00393	CbGpPWpGaD
Alfentanil—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000186	0.00389	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.000186	0.00389	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000181	0.00379	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.000175	0.00366	CbGpPWpGaD
Alfentanil—ALB—Folate Metabolism—IL4—primary biliary cirrhosis	0.000174	0.00365	CbGpPWpGaD
Alfentanil—ALB—Selenium Micronutrient Network—GGT1—primary biliary cirrhosis	0.000172	0.00361	CbGpPWpGaD
Alfentanil—OPRM1—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000167	0.00351	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000164	0.00344	CbGpPWpGaD
Alfentanil—CYP3A7—Biological oxidations—GGT1—primary biliary cirrhosis	0.000162	0.00339	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000156	0.00326	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000148	0.0031	CbGpPWpGaD
Alfentanil—OPRM1—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000144	0.00302	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.000141	0.00296	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—CD40LG—primary biliary cirrhosis	0.000136	0.00285	CbGpPWpGaD
Alfentanil—ABCB1—HIF-1-alpha transcription factor network—HIF1A—primary biliary cirrhosis	0.000132	0.00277	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—IL4—primary biliary cirrhosis	0.000132	0.00277	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.00013	0.00272	CbGpPWpGaD
Alfentanil—OPRM1—TCR Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000128	0.00267	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	0.000121	0.00255	CbGpPWpGaD
Alfentanil—OPRM1—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.00012	0.00252	CbGpPWpGaD
Alfentanil—ABCB1—HIF-1-alpha transcription factor network—NOS2—primary biliary cirrhosis	0.00012	0.00252	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—RAD51B—primary biliary cirrhosis	0.000119	0.00248	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—GGT1—primary biliary cirrhosis	0.000117	0.00245	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000112	0.00235	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—LBR—primary biliary cirrhosis	0.000111	0.00233	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PDE5A—primary biliary cirrhosis	0.00011	0.00231	CbGpPWpGaD
Alfentanil—ALB—Vitamin B12 Metabolism—NFKB1—primary biliary cirrhosis	0.000108	0.00226	CbGpPWpGaD
Alfentanil—ALB—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000106	0.00222	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000102	0.00214	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.000102	0.00213	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	0.000101	0.00212	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	9.66e-05	0.00202	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	9.44e-05	0.00198	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	9.27e-05	0.00194	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	9.27e-05	0.00194	CbGpPWpGaD
Alfentanil—ALB—Folate Metabolism—NFKB1—primary biliary cirrhosis	8.76e-05	0.00183	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	8.74e-05	0.00183	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	8.55e-05	0.00179	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	8.42e-05	0.00176	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	8.08e-05	0.00169	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—OGDH—primary biliary cirrhosis	8.05e-05	0.00169	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—LBR—primary biliary cirrhosis	8.05e-05	0.00169	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—CCL5—primary biliary cirrhosis	7.36e-05	0.00154	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PDHX—primary biliary cirrhosis	7.18e-05	0.0015	CbGpPWpGaD
Alfentanil—ALB—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	6.96e-05	0.00146	CbGpPWpGaD
Alfentanil—ALB—Metabolism—LBR—primary biliary cirrhosis	6.94e-05	0.00145	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—DLAT—primary biliary cirrhosis	6.75e-05	0.00141	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ABCB4—primary biliary cirrhosis	6.75e-05	0.00141	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—AGT—primary biliary cirrhosis	6.15e-05	0.00129	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	6.15e-05	0.00129	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—LBR—primary biliary cirrhosis	6.08e-05	0.00127	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	5.9e-05	0.00124	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—OGDH—primary biliary cirrhosis	5.82e-05	0.00122	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDH5—primary biliary cirrhosis	5.69e-05	0.00119	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCR5—primary biliary cirrhosis	5.48e-05	0.00115	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	5.44e-05	0.00114	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	5.39e-05	0.00113	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	5.39e-05	0.00113	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PDHX—primary biliary cirrhosis	5.19e-05	0.00109	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	5.17e-05	0.00108	CbGpPWpGaD
Alfentanil—ALB—Metabolism—OGDH—primary biliary cirrhosis	5.01e-05	0.00105	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	5.01e-05	0.00105	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCL9—primary biliary cirrhosis	4.97e-05	0.00104	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—DLAT—primary biliary cirrhosis	4.88e-05	0.00102	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ABCB4—primary biliary cirrhosis	4.88e-05	0.00102	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	4.83e-05	0.00101	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	4.72e-05	0.00099	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ELMO1—primary biliary cirrhosis	4.6e-05	0.000964	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	4.52e-05	0.000948	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PDHX—primary biliary cirrhosis	4.47e-05	0.000937	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	4.39e-05	0.000921	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	4.39e-05	0.00092	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	4.39e-05	0.000919	CbGpPWpGaD
Alfentanil—ALB—Metabolism—DLAT—primary biliary cirrhosis	4.2e-05	0.000881	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCB4—primary biliary cirrhosis	4.2e-05	0.000881	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	4.16e-05	0.000871	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—NUP210—primary biliary cirrhosis	4.06e-05	0.00085	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—MMP3—primary biliary cirrhosis	4e-05	0.000838	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	3.92e-05	0.000821	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	3.87e-05	0.000811	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CCL5—primary biliary cirrhosis	3.77e-05	0.000791	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ABCG2—primary biliary cirrhosis	3.77e-05	0.00079	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	3.74e-05	0.000785	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	3.68e-05	0.000772	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	3.68e-05	0.000772	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AGT—primary biliary cirrhosis	3.48e-05	0.000729	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	3.44e-05	0.000722	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	3.28e-05	0.000687	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CTGF—primary biliary cirrhosis	3.24e-05	0.000678	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GOT2—primary biliary cirrhosis	3.21e-05	0.000672	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AGT—primary biliary cirrhosis	3.16e-05	0.000662	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NUP210—primary biliary cirrhosis	2.93e-05	0.000614	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GGT1—primary biliary cirrhosis	2.77e-05	0.00058	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GOT1—primary biliary cirrhosis	2.77e-05	0.00058	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ABCG2—primary biliary cirrhosis	2.73e-05	0.000571	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	2.71e-05	0.000567	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NOS2—primary biliary cirrhosis	2.69e-05	0.000564	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	2.68e-05	0.000562	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCL10—primary biliary cirrhosis	2.59e-05	0.000543	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NUP210—primary biliary cirrhosis	2.53e-05	0.000529	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPARGC1A—primary biliary cirrhosis	2.46e-05	0.000516	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	2.41e-05	0.000506	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP3—primary biliary cirrhosis	2.36e-05	0.000495	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—TYK2—primary biliary cirrhosis	2.36e-05	0.000495	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCG2—primary biliary cirrhosis	2.35e-05	0.000492	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CTGF—primary biliary cirrhosis	2.34e-05	0.00049	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GOT2—primary biliary cirrhosis	2.32e-05	0.000486	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	2.27e-05	0.000475	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	2.27e-05	0.000475	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCL5—primary biliary cirrhosis	2.23e-05	0.000467	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	2.21e-05	0.000464	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.16e-05	0.000453	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	2.06e-05	0.000431	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CTGF—primary biliary cirrhosis	2.01e-05	0.000422	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GGT1—primary biliary cirrhosis	2e-05	0.000419	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GOT1—primary biliary cirrhosis	2e-05	0.000419	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GOT2—primary biliary cirrhosis	2e-05	0.000418	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AGT—primary biliary cirrhosis	1.92e-05	0.000402	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.87e-05	0.000392	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AGT—primary biliary cirrhosis	1.87e-05	0.000391	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARGC1A—primary biliary cirrhosis	1.78e-05	0.000373	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	1.76e-05	0.00037	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	1.75e-05	0.000367	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GGT1—primary biliary cirrhosis	1.72e-05	0.000361	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GOT1—primary biliary cirrhosis	1.72e-05	0.000361	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.71e-05	0.000359	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CD80—primary biliary cirrhosis	1.65e-05	0.000346	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARGC1A—primary biliary cirrhosis	1.53e-05	0.000321	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	1.51e-05	0.000316	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	1.51e-05	0.000316	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALB—primary biliary cirrhosis	1.47e-05	0.000309	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TYK2—primary biliary cirrhosis	1.4e-05	0.000292	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AGT—primary biliary cirrhosis	1.39e-05	0.000291	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	1.36e-05	0.000286	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.34e-05	0.000282	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	1.27e-05	0.000266	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AGT—primary biliary cirrhosis	1.19e-05	0.00025	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP9—primary biliary cirrhosis	1.1e-05	0.00023	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	1.09e-05	0.000228	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.09e-05	0.000228	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	1.08e-05	0.000226	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALB—primary biliary cirrhosis	1.06e-05	0.000223	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AGT—primary biliary cirrhosis	1.05e-05	0.000219	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	9.3e-06	0.000195	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	9.3e-06	0.000195	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	8.28e-06	0.000173	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALB—primary biliary cirrhosis	8.03e-06	0.000168	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	6.45e-06	0.000135	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	4.95e-06	0.000104	CbGpPWpGaD
